Pharmacy Law Flashcards

1
Q

Pure Food and Drug Act

A
  • 1906
  • Prohibits the interstate transportation/sale of adulterated/misbranded food/drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Food Drug and Cosmetic Act

A
  • 1938
  • Creates the Food and Drug Administration
  • All new drug applications must be filed with the FDA
  • Defines adulteration and misbranding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State vs. Federal Law

A
  • Federal law takes precedence unless state law is stricter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adulteration

A
  • Composed in whole or part of any filthy, putrid, or decomposed substance
  • Prepared, packed, or held in unsanitary conditions
  • Prepared in containers composed in whole or part of any poisonous or deleterious substance
  • Containing unsafe color additives
  • Claimed/represented to be a drug recognized in an official compendium, but differing in strength, quality, or purity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Misbranding

A
  • Containing any false/misleading info
  • Failure to have the name and place of business of the manufacturer/packer/distributor, accurate quantity of contents, or any other required info clearly and conspicuously displayed
  • Failure to have warning “Warning: may be habit forming”
  • Failure to have the established name of the active ingredients and quantities if there are multiple ingredients, quantity of alcohol, and established name and quantity of any other required substance
  • Failure to have adequate directions for use or warning against use in certain pathological conditions
  • If the drug is hazardous to health due to the manner of use, dosage, or duration recommended/prescribed/suggested by the label
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Durham-Humphrey Act

A
  • 1951
  • All drugs must have directions for use or warning “Caution: Federal law prohibits dispensing without a prescription”
  • Separates legend and non-legend drugs
  • Prescriptions may be verbally received via phone
  • Refills may be called in by physician’s office
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Kefauver-Harris Act

A
  • 1962
  • All meds must be safe, pure, and effective
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Comprehensive Drug Abuse Prevention and Control Act

A
  • 1970
  • Creates the Drug Enforcement Agency under the Department of Justice
  • Places controlled substances in 5 schedules based on accepted medical use and potential for abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Schedule I

A
  • No medical use, very high abuse potential
    • Crack cocaine
    • Crystal methamphetamine
    • Ecstasy
    • Hashish
    • Hash oil
    • Heroin
    • Marijuana
    • Mescaline
    • Opium
    • Phencyclidine Palmitate
    • Peyote
    • Psilocybin
    • Rohypnol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Schedule II

A
  • Accepted medical use, high psychological or physical abuse potential
    • Adderall
    • Amytal
    • Cocaine
    • Codeine
    • Demerol
    • Dexedrine
    • Dilaudid
    • Dolophine
    • Duragesic
    • Morphine Sulfate
    • Numorphan
    • OxyContin
    • Percocet
    • Percodan
    • Ritalin
    • Seconal
    • Tylox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Schedule III-V

A
  • III - lower abuse potential
  • IV - even lower abuse potential
  • V - lowest abuse potential, includes exempt narcotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DEA Registration

A
  • Must be registered with DEA to dispense controlled substances
  • Use DEA form 224
  • Must be renewed every 3 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Schedule II Ordering

A
  • Person registered with DEA must fill out DEA form 222 with typewriter/pen/indelible pencil
  • DEA form 222 is valid for 60 days
  • Must be one item per line, max of 10 per form, totaled at bottom
  • Unused forms to be kept in secure location in pharmacy
  • Upon receipt, number or packages to be recorded on retained copy of form which is also to be signed and dated
  • Invoice and form kept for 2 years in secure location
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Schedule III-V Ordering

A
  • Can be ordered by fax, telephone, writing
  • Invoice must be signed, dated, stamped with red C
  • Must be kept in secure location for 2 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DEA Records

A
  • Must be kept for 2 years and readily retrievable
  • Readily retrievable = separate from other business records or designated with a visual indication (red line/asterisk), a red C must be stamped on schedule III-V invoices if filed with others
  • Must be given to DEA agent within 72 upon request
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Defective DEA forms

A
  • Incomplete, illegible, or showing signs of alteration, erasure, or change
  • Must be readily retrievable and kept for 2 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Controlled Substance Inventories

A
  • Initial - taken before the opening of the first business day, a complete and accurate count of all controlled substances
  • Biennial - taken every two years, an exact count of schedule II and estimate of schedules III-V, records must be kept for 2 years
  • Perpetual - records drugs received, supplied to other locations, returned to pharmacy, and dispensed to patient, shows the actual number of units of a drug at a particular time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Return of Controlled Substances

A
  • Can be returned only between DEA registrants
  • Use DEA form 222 for schedule II
  • Cannot be returned from long-term care facilities which don’t have DEA numbers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Destruction of Outdated/Damaged Controlled Substances

A
  • Use DEA form 41 to record name, strength. and quantity of the drug, as well as, date and method of destruction and witness
  • Retail pharmacies have one form 41 per year
  • Hospitals may have blanket authorization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Theft of Controlled Substances

A
  • Must be reported to the nearest DEA division office and local police
  • Use form 106 and retain a copy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Filling of Schedule II

A
  • Computer generated or handwritten, signed by physician in pen
  • No refills
  • Can be partially filled if remaining amount is available within 72 hours, but a new prescription is needed for additional quantities after 72 hours, pharmacist should notify physician if unavailable
  • Can have emergency filling, can be an oral prescription, good faith attempt must be made to identify the physician, only the amount required to treat the patient at that time, reduced to writing by pharmacist, physician must write a prescription that is received within 7 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Filling of Schedule II in Long-Term Care Facilities

A
  • Prescription may be faxed and treated as original, but must be retained
  • Partial filling is allowed for patients in a long-term care facility or diagnosed with a terminal illness for 60 days unless prescription is discontinued sooner
  • Note must be made on prescription that it’s for a long-term care facility/terminally ill patient or it violates federal law
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Filling of Schedule III-V

A
  • Computer generated or handwritten, signed by physician in pen, verbal and faxed prescriptions according to state law
  • 5 refills within 6 months if authorized
  • Partial filling is allowed provided refills are allowed, refills don’t exceed the total quantity prescribed, and no partial filling occurs after 6 months
24
Q

Exempt Narcotics

A
  • Certain cough and antidiarrheal medications may be purchased by individuals
  • Must be in the original manufacturer’s packaging and not exceeding quantity according to law
  • Purchaser must be 18+ and sign the exempt narcotic book with name, address, name and quantity of drug, price, and pharmacist’s signature
  • Only 1 container within 48 hours
25
Q

Facsimile Prescriptions

A
  • For schedules III-V may be treated as original
  • Allowed for schedule II drugs:
    • That will be compounded and directly administered to patient as a parenteral, intravenous, intramuscular, subcutaneous, or intraspinal infusion
    • For a long-term care facility patient
    • For a patient in hospice (certified by Medicare title XVIII or licensed by state law) whether or not the patient is in the hospice facility or other care setting, may be transmitted by practitioner’s agent, must note it’s for a hospice patient
26
Q

National All Schedules Prescription Electronic Reporting Act

A
  • 2005, never enacted
  • Electronic system for practitioner monitoring of dispensing of schedules II-IV
  • Required reporting of specific info including patient ID, name and quantity of drug, prescriber, and dispenser
27
Q

Transfer of Controlled Substance Prescriptions

A
  • Allowed only once unless the two pharmacies share an online, real time database
  • Must be between two licensed pharmacists
  • Transferor: must write void on prescription as well as receiving pharmacy name, address, and DEA number, receiving and transferring pharmacists’ names, and date
  • Receiver: must write transfer on prescription as well as the original date of issue and dispensing, number of refills total and remaining, date and location of previous refills, transferring pharmacy’s name, address, DEA number, and prescription number, transferring pharmacist’s name, and the name, address, DEA number, and prescription number of pharmacy to originally fill the prescription
28
Q

Poison Prevention Packaging Act

A
  • 1970
  • Reduce accidental poisoning in children
  • Most OTC and prescription drugs must have child resistant packaging
  • Child resistant = unable to be opened by 80% of children < 5, but able to be opened by 90% of adults
29
Q

Exceptions for Child Resistant Containers

A
  • Single time as ordered by presciber
  • Single time/blanket as ordered by customer in signed statement
  • One OTC container for elderly or handicapped with warning “This package for households without children” or “Package not child resistant
  • For institutionalized patients if administered by employee of institution
30
Q

Medications Not Requiring Child Resistant Containers

A
  • Sublingual nitrogylcerin tablets
  • Inhalation aerosols
  • Pancrelipase preparations
  • Oral contraceptives taken cyclically and still in manufacturer’s packaging
  • Powdered anhydrous cholestyramine
  • Betamethasone < 12.6mg
  • Erythromycin ethylsuccinate < 16g
  • Mebendazole tablets < 600mg
  • Methylprednisolone tablets < 85mg
  • Sublingual/chewable isosorbide dinitrate < 10mg
  • Powdered cholestipol < 5g
  • Prednisone tablets < 105mg
  • Sodium fluoride < 264mg
31
Q

Occupational Health and Safety Act

A
  • 1970
  • Created the Occuptional Health and Safety Administration
  • Ensures a safe and healthful workplace for all employees
  • Ensures job safety, health standards, a reporting system for job related illnesses/injuries, a reduction in hazards, and audits to ensure compliance
  • Addresses the following in pharmacies: air contaminants, flammable and combustible liquids, skin and eye protection, and hazard communication standards
  • Requires material safety data sheets which are issued by the seller
  • Issues guidelines for cytotoxic (antineoplastic) drugs
32
Q

Drug Listing Act

A
  • 1972
  • Assigns each drug an 11-digit ID number called the National Drug Code
    • first 5 digits - manufacturer ID
    • next 4 digits - product ID
    • last 2 digits - size and packaging ID
33
Q

Orphan Drug Act

A
  • 1983
  • Orphan drugs treat diseases with < 200,000 cases worldwide
  • Provides tax incentives and exclusive licensing of products to develop and market orphan drugs
34
Q

Drug Price Competition and Patent Term Restoration Act

A
  • 1984
  • Encourages the creation of new and generic drugs by streamlining the process for generic drug approval and extending patent licenses
35
Q

Prescription Drug Marketing Act

A
  • 1987
  • Prohibits reimportation of a drug in the US by anyone other than the manufacturer
  • Prohibits the sale/distribution of samples to anyone other than those licensed to prescribe them
  • Requires any drug to be administered to an animal to have the label “Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian
36
Q

Omnibus Budget Reconciliation Act 1

A
  • 1987
  • Extensive revisions to Medicare/Medicaid regarding long-term care and pharmacy
  • Residents’ drug regimens must be free of unnecessary meds
  • Antipsychotic drugs are not to be used unless the patient has a specific condition
  • Residents requiring antipsychotics must be documented as dianosed with a condition warranting use
  • Patients receiving antipsychotics must receive gradual dose tapering
  • Behavioral modificaton and med holidays are to be used to see if the med can be discontinued
  • Residents must be free of significant med errors
  • Routine and emergency drugs must be provided to patients
  • Long-term care facilities must have the services of a consultant pharmacist
  • Meds must be labeled according to professional principles
  • Meds must be in locked comparments at the proper temp according to state and federal law
37
Q

Anaboic Steroid Control Act 1

A
  • 1990
  • Harsher penalties for the abuse of anabolic steroids and misuse by athletes
38
Q

Omnibus Budget Reconciliation Act 2

A
  • 1990
  • Manufacturers must provide the lowest price to a medicaid patient by rebating the state the difference between the average and lowest prices
  • Patients must receive an offer to counsel
  • Drug utilization reviews must be performed
  • Allows government sponsored demonstrations relating to the provision of pharmaceutical care
  • Patient profiles must be maintained
39
Q

FDA Safe Medical Devices Act

A
  • 1990
  • All medical devices must be tracked and records must be maintained for durable medical goods
40
Q

Americans with Disabilities Act

A
  • 1990
  • Prevents discrimination against potential employees
  • Busineses must make a reasonable accomodation for the potential employee
41
Q

Resource Conservation and Recovery Act

A
  • Environmental Protection Agency (EPA) produced guidelines for the disposal of hazardous waste
  • Controlled substances = hazardous waste
  • Flushing is not an acceptable method of destrution in many states
42
Q

FDA Modernization Act

A
  • In the federal drug legend (“Federal law prohibits dispensing without a prescription”) prescription is abbreviated to Rx
43
Q

Dietary Supplement Health and Education Act

(DSHEA)

A
  • 1994
  • Herbal products are dietary supplements, not drugs
  • Manufacturers may make claims about general health promotion, but not disease claims
  • Must be labeled as dietary supplements
  • Labeling must list all the ingredients by name
  • Packaging must have the plant and plant part from which the supplement derives
  • Must comply with standards set by official compendium
  • Must adhere to quality, purity, and compositional specifications
  • There are guidelines to prevent adulteration and manufacturers must use good manufacturing processes
44
Q

Health Insurance Portability and Accountability Act

(HIPAA)

A
  • 1996
  • Title I - insurance reform, protects health insurance coverage for workers and their families when they chage or lose their jobs
  • Title II - administration simplifiction, establishes electronic transaction and code set standards, requires health information privacy
  • Improves portability and continuity of coverage for groups and indiviuals
  • Combats waste, fraud, and abuse in insurance and health care delivery
  • Promotes the use of medical savings accounts
  • Improves access to long-term care services and coverage
  • Simplifies the administration of insurance
  • Requires health care providers to maintain confidentiality
  • Sets boundaries on the use and disclosure of protected information
  • Requires patients to be informed of how their information will be used
45
Q

HIPAA Protected Information

A
  • Information relating to past/present/future physical/mental health
  • Information relating to past/present/future payments for health services received
  • Information relating to past/present/future specific care
  • Information that can identify the patient as the individal receiving care
  • Information that could reasonably be used to identify a patient as receiving care
46
Q

Isotretinoin Safety and Risk Management Act

A
  • 2004
  • Accutane can cause severe birth defects, spontaneous abortions, and psychiatric effects including depression, psychosis, suicidal ideation, suicide attempts, and suicide
  • Mandatory registry of patients, practitioners, and pharmacists
  • Education of practitioners and pharmacists
  • Can only be prescribed for severe recalcitrant nodular acne, for which it was approved, that has not responded to conventional treatment including antibiotics
  • Monthly education of patients regarding need to avoid pregnancy, including one-on-one counselig
  • Patient completion of survey about adverse effects
  • Patient must sign informed consent form
  • Certification of medical offices and clinics as treatment centers
  • No internet, phone, or mail order prescriptions
  • 30 day prescription allotments
  • Female patients must take monthly pregnancy test to renew
  • Appropriate blood testing during treatment and 30 days after
  • Yearly evaluation of treatment centers to ensure compliance
  • Mandatory quarterly reporting of adverse effects and reporting within 15 days for deaths associated with drug
47
Q

Anabolic Steroid Act 2

A
  • 2004
  • Redefines anabolic steroid so it doesn’t have to be proven that they cause muscle gain to be schedule III
  • Increased number of anabolic steroids to 59
  • Requirements for registration, security, labeling and packaging, inventory, record maintenance, prescriptions, disposal, importation and exportation, and criminal liability
48
Q

Any Willing Provider Law

A
  • Allows any pharmacy to participate in a prescription drug benefit plan as long as the pharmacy agrees to the terms and conditions of the plan
49
Q

Freedom of Choice Law

A
  • Allows a member of a prescription drug plan to select any pharmacy for his/her benefit as long as the pharmacy agrees to the terms and conditions of the plan
50
Q

Freedom of Choice with Regard to Long Term Care

A
  • Long-term care residents may choose an outside pharmacy for meds if pharmaeutical service isn’t in their contract
  • Long-term care facilities may refuse residents if they refuse to use the drug distribution system already in place
  • Long-term care facilities may establish policies to protect patients and may require outside pharmacies to agree to these policies
51
Q

Prescription Drug Equity Law

A
  • Prohibits a prescription drug plan from requiring mail order prescription drug coverage without also providing non-mail order coverage
52
Q

Medicare Drug, Improvement, and Modernization Act

(MPDIMA)

A
  • 2003
  • Provides voluntary prescription drug benefits for Medicare
  • Adds preventive medical benefits for senior citizens
  • Lowers reimbursement rates for Medicare payment for durable medical equipment
  • In 2007, created a national competitive bidding program for durable medical equipment
  • Changes how Medicare pays for outpatient Part B drugs
  • Allows voluntary Medicare approved discount card program beginning June 2004
  • Medicare Part D prescription plan allows beneficiaries to enroll in regional or national insurance plans
53
Q

Combat Methamphetamine Epidemic Act

A
  • 2005
  • Puts ephedrine, pseudoephedrine, and phenylpropanolamine in the new Controlled Substances Act category of scheduled listed chemical products
  • Products containing these are subject to sales restrictions, storage requirements, and record keeping requirements
  • 3.6g/day base product sales limit
  • 9g/30days base product sales
  • Blister package requirement
  • Mail order restrictions
  • Logbooks require product’s name and quantity, name and address of purchaser, and date and time of sale
54
Q

Medicaid Tamper Resistant Prescription Act

A
  • Effective April 1, 2008:
  • Applies to handwritten prescriptions for covered outpatient dugs
  • Tamper resistant pads must have one of the following:
    • 1+ industry recognized features designed to prevent unauthorized copying of completed or blank prescription forms
    • 1+ industry recognized features designed to prevent erasure/modification of written information
    • 1+ industry recognized features designed to prevent use of counterfeit prescription forms
  • Effective November 1, 2009:
    • A prescription pad needs all three features to be considered tamper resistant
  • Restrictions don’t apply to prescriptions before April 1, 2008
  • If a pharmacy questions whether the pad meets the requirements, they may call the prescriber for verification
  • A pharmacy may accept faxed prescriptions until the prescriber’s office obtains tamper-resistant pads
  • A pharmacy may fill an emergency prescription if they receive documentation within 72 hours
  • A pharmacy may transfer to another pharmacy by fax or phone and the second pharmacy doesn’t need direct confirmation from the prescriber
55
Q

USP <797>

A
  • Cuts down on infections transmitted to patients via pharmaceutical products and protects pharmacy staff
  • Contains procedural training and quality assurance requirements for preparing sterile products
  • Affects health care institutions, pharmacies, physician’s practices, and other facilities in which compounded sterile preparations are prepared, stored, and dispensed
  • Facilities affected include those in which sterile products are prepared according to manufacturer’s labeling and where manipulations are performed during the compounding of sterile products that increase the potential for microbial contamination of the end product
  • Affects facilities using unsterilized devices/compounds to prepare compounds that must be sterilized
  • Products may be biologics, diagnostic agents, drugs, nutrients, or radiopharmaceuticals
    • Includes baths/soaks for live organs and tissues, implants, inhalations, injections, irrigations, metered spray, opthalmic/otic preparations
56
Q

USP <797> Specifics

A
  • Microbial contamination risk levels (low, medium, high-risk conditions)
  • Personnel training and evaluation in aspetic manipulation skills
  • Clean rooms to include anterooms, air classification, physical characteristics of the construction, and gowning procedures
  • Barrier isolators
  • Formalized quality assurance program
  • Minimum requirements for validation
  • Cleaning and sanitizing workspaces
  • Environmental monitoring
  • Verification of automated compounding devices for nutrition compounding